Bridgford Foods (BRID) vs Clene (CLNN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bridgford Foods (BRID) has outperformed Clene (CLNN) over the past year, losing 26.2% versus a loss of 58.8%. Over five years, BRID leads with a -54.2% price change compared with -96.9% for CLNN. Clene is the larger company by market cap ($55.3 million vs $53.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRID | CLNN |
|---|---|---|
| Share price | $5.90 | $3.89 |
| Market cap | $53.55M | $55.28M |
| 1-day change | 0.00% | +0.23% |
| YTD return | -24.36% | -33.90% |
| 1-year return | -26.25% | -58.81% |
| 5-year return | -54.16% | -96.86% |
| EPS (TTM) | $-1.60 | $-3.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.62 | $13.50 |
| 52-week low | $5.34 | $3.25 |
| Distance from 52-week high | -31.55% | -71.19% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +728.00% |
| Average volume | 3.53K | 100.21K |
| Shares outstanding | 9.08M | 14.21M |
| Employees | 649 | 76 |
| Sector | Consumer Staples | Health Care |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BRID has outperformed CLNN by 32.6 percentage points over the past year.
- The two companies sit in different sectors: Bridgford Foods in Consumer Staples and Clene in Health Care.
About Bridgford Foods
BRID stock →Bridgford Foods Corporation, together with its subsidiaries, engages in the manufacture, marketing, and distribution of frozen and snack food products in the United States. The company operates in two segments, Frozen Food Products and Snack Food Products.
Consumer Staples · Specialty Foods · 649 employees
About Clene
CLNN stock →Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 76 employees
BRID vs CLNN FAQ
Which is bigger, Bridgford Foods or Clene?
Clene (CLNN) is larger, with a market capitalization of $55.28M compared with $53.55M for Bridgford Foods (BRID).
Which stock has performed better over the past year, BRID or CLNN?
BRID returned -26.25% over the past 12 months, compared with -58.81% for CLNN (price return, excluding dividends). Past performance does not predict future results.
Are Bridgford Foods and Clene in the same industry?
No. Bridgford Foods is in the Consumer Staples sector, while Clene is in Health Care.